Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer.
Meier C, La Rocca G, Nawrot V, Fißlthaler B, Overby SJ, Hourfar K, Plotz G, Seidl C, Ziegler P, Wild P, Zeuzem S, Brieger J, Jäger E, Battmann A, Brieger A.
Meier C, et al. Among authors: brieger j.
Int J Mol Sci. 2024 May 23;25(11):5658. doi: 10.3390/ijms25115658.
Int J Mol Sci. 2024.
PMID: 38891846
Free PMC article.